New drug doubles Melanoma survival time
NEW YORK (WABC) -- There's an important new weapon in the fight against skin cancer.
It's a drug called Zelboraf.
A study found it can double the survival time of people with malignant melanoma, from eight months to 16 months.
The disease kills 9,000 people each year in the U.S.
It's usually fatal once it spreads.
Doctors say if you notice anything that's changed on your skin, have it checked immediately.
Get Eyewitness News Delivered
health alert, cancer, skin cancer, health news
- Third grader killed in accident, truck driver charged 43 min ago
- AccuWeather: Warmer stretch arrives 30 min ago
- Live: Eyewitness News on 7online streamed live!
- iWitness Photos and Videos
- Car dealer charged after selling Sandy-damaged vehicles 43 min ago
- NJ Transit train disabled inside Hudson River tunnel
- Surveillance released in shooting of 9-year-old boy
- Man stabbed on 2 train in Bronx
- Prosecutors likely to reduce charges in SUV assault
- Video: Two US astronauts set to spacewalk to fix ISS 29 min ago
- GWB repair work this weekend
- Father in Army reunites with son in kindergarten class
- Photos: Deadly fire in the Bronx
- Target data breach: 7 Things to know
- Third grader killed in accident, truck...
43 min ago
- Car dealer charged after selling...
43 min ago
- AccuWeather: Warmer stretch arrives
30 min ago
- Two US astronauts set to spacewalk to fix ISS
29 min ago
Most Viewed StoriesMost Viewed Photos